Robert Iannone
Executive Vice President, R&D and Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $793,077 | $8,661,758 |
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $750,692 | $5,689,377 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $720,526 | $4,979,077 |
| 2022 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of R&D | $663,672 | $4,855,654 |
| 2021 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $591,923 | $4,001,336 |
| 2020 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $592,308 | $3,149,481 |
| 2019 | Jazz Pharmaceuticals plc (JAZZ) | M.D., M.S.C.E Executive Vice President, Global Head of Research and Development | $313,077 | $3,693,560 |
Earnings-call appearances
-
Jazz Pharmaceuticals plc Q3 FY2025 Earnings Call2025-11-05
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q2 FY2025 Earnings Call2025-08-05
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2024 Earnings Call2025-02-25
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2024 Earnings Call2024-05-01
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2023 Earnings Call2023-11-08
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2023 Earnings Call2023-05-10
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q4 FY2021 Earnings Call2022-03-01
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q3 FY2021 Earnings Call2021-11-09
Jazz Pharmaceuticals plc (JAZZ)
-
Jazz Pharmaceuticals plc Q1 FY2021 Earnings Call2021-04-20
Jazz Pharmaceuticals plc (JAZZ)